넥살린 테크놀로지(NXL)는 NASDAQ에 상장된 Healthcare · Medical Devices 기업입니다. 현재가 $4.97 (-2.53%), 시가총액 $0.01B, 52주 최저~최고 $0.32 ~ $1.86.
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas.
넥살린 테크놀로지의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
넥살린 테크놀로지의 현재 주가는 $4.97 (-2.53%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
넥살린 테크놀로지의 시가총액은 약 $0.01B입니다.
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Genera